SABSW

distress 6/10 · elevated risk

$0.01-35%today-69% from 52w high

sab.bio86 employeesFounded 2014Miami Beach, FL

Revenue

pre-revenue

Liquidity

$218M

Runway

4.3 yrs

Shares 1y

+635%

Price & events

-63.8% over 6M

CatalystRating changeDilutionFinancingdashed = today

-35.3%

-38.8%

-68.7%

—

-63.8%

All

Overview

Market Cap: $856.40K
Volume: 32.06K
52 Week Range: $0.01 – $0.04
Total Shares: 76.46M
Float Shares: 41.20M
RVOL: 2.37x
Beta: 0.53

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 76,464,094 · 3 offerings/1y · 0 PIPEs

2026-05-048-Kmaterial_agreement
2026-03-198-Kmaterial_agreement
2026-03-19424B5offering
2026-03-17424B5offering
2026-01-07EFFECTshelf_effective
2025-12-29S-3shelf_registration
2025-11-12424B3offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified